ISHLT Acellular Ex Vivo Lung Perfusion (EVLP) Research Grant
Forecasted
ISHLT Acellular Ex Vivo Lung Perfusion (EVLP) Research Grant supports researchers studying perfusion optimization, repair, and clinical outcomes to advance acellular lung perfusion technology.
Funder: International Society for Heart and Lung Transplantation
Due Dates (Anticipated): September 2027 (Application deadline)
Funding Amounts: One grant of up to $37,500 USD for one year
Summary: Supports research advancing acellular ex vivo lung perfusion through perfusion optimization, repair, immunomodulation, reconditioning, and outcomes research.
Key Information: Applicants must be active ISHLT members or submit a completed membership application by the application deadline.
Description
The International Society for Heart and Lung Transplantation (ISHLT) administers this research grant with support from Lung Bioengineering. The program funds work aimed at further advancing acellular ex vivo lung perfusion (EVLP) technology. Its scope includes optimization of perfusion techniques, intervention and repair strategies, immunomodulation and reconditioning, and outcomes research, including clinical outcomes.
The one-year award supports researchers with academic or clinical appointments, as well as eligible trainees with institutional support or an accepted faculty position. Funding can support research personnel and practical study resources, alongside publication and abstract-presentation costs. Proposals are assessed by expert reviewers for their scientific aims, significance, innovation, research approach, data feasibility, and prior work.
